Loading...
XNYS
RFL
Market cap83mUSD
Jul 09, Last price  
2.27USD
1D
-7.35%
1Q
80.16%
IPO
-53.02%
Name

Rafael Holdings Inc

Chart & Performance

D1W1MN
XNYS:RFL chart
P/E
—
P/S
90.97
EPS
—
Div Yield, %
—
Shrs. gr., 5y
13.29%
Rev. gr., 5y
-28.51%
Revenues
917k
+43.96%
3,987,0005,589,0005,618,0004,371,0004,931,0004,910,000802,000410,000279,000637,000917,000
Net income
-31m
L-11.30%
-467,000710,000138,000-11,649,000-4,924,000-10,415,000-24,544,000-124,658,000-1,876,000-34,410,000-30,520,000
CFO
-19m
L+142.55%
-571,00072,000-1,623,000-1,815,000-3,132,000-4,666,000-15,601,000-26,079,000-10,886,000-7,802,000-18,924,000
Dividend
Dec 18, 20090.02 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones. The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
URL
https://rafaelholdings.com
IPO date
Mar 12, 2018
Employees
22
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑072024‑072023‑072022‑072021‑072020‑072019‑072018‑072017‑072016‑07
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT